News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,148 Results
Type
Article (86467)
Company Profile (702)
Press Release (758979)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232669)
Career Advice (4127)
Deals (39718)
Drug Delivery (129)
Drug Development (90981)
Employer Resources (198)
FDA (18102)
Job Trends (17332)
News (396437)
Policy (39744)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56827)
ALS (99)
Alzheimer's disease (1501)
Antibody-drug conjugate (ADC) (156)
Approvals (18068)
Artificial intelligence (325)
Autoimmune disease (29)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (481)
Bladder cancer (84)
Brain cancer (32)
Breast cancer (303)
Cancer (2432)
Cardiovascular disease (203)
Career advice (3534)
Career pathing (34)
CAR-T (172)
Cell therapy (489)
Cervical cancer (21)
Clinical research (73388)
Collaboration (910)
Compensation (543)
Complete response letters (30)
COVID-19 (2867)
CRISPR (48)
C-suite (264)
Cystic fibrosis (107)
Data (2261)
Decentralized trials (2)
Denatured (45)
Depression (55)
Diabetes (298)
Diagnostics (6919)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (127)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (96625)
Editorial (44)
Employer branding (25)
Employer resources (167)
Events (129976)
Executive appointments (773)
FDA (19421)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (815)
Gene editing (119)
Generative AI (35)
Gene therapy (357)
GLP-1 (852)
Government (5158)
Grass and pollen (6)
Guidances (59)
Healthcare (20886)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (146)
Indications (30)
Infectious disease (3028)
Inflammatory bowel disease (152)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (101)
Interviews (812)
IPO (17815)
IRA (51)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (555)
Leadership (24)
Legal (10113)
Liver cancer (81)
Lung cancer (345)
Lymphoma (158)
Machine learning (7)
Management (65)
Manufacturing (351)
MASH (74)
Medical device (14636)
Medtech (14641)
Mergers & acquisitions (22443)
Metabolic disorders (787)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (114)
Neuropsychiatric disorders (34)
Neuroscience (2105)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (40)
Obesity (423)
Opinion (275)
Ovarian cancer (78)
Pain (97)
Pancreatic cancer (86)
Parkinson's disease (161)
Partnered (24)
Patents (250)
Patient recruitment (114)
Peanut (51)
People (65288)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22644)
Phase II (31859)
Phase III (24012)
Pipeline (1236)
Policy (170)
Postmarket research (3552)
Preclinical (10220)
Press Release (72)
Prostate cancer (113)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (430)
Real estate (7392)
Recruiting (75)
Regulatory (26783)
Reports (57)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (80)
Series A (142)
Series B (91)
Service/supplier (30)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4291)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (45)
The Weekly (82)
Vaccines (810)
Venture capitalists (44)
Weight loss (304)
Women's health (40)
Worklife (20)
Date
Today (179)
Last 7 days (912)
Last 30 days (2830)
Last 365 days (35886)
2025 (11687)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (268)
Arkansas (14)
Asia (50124)
Australia (8829)
California (6410)
Canada (2054)
China (560)
Colorado (283)
Connecticut (300)
Delaware (158)
Europe (114959)
Florida (937)
Georgia (219)
Hawaii (1)
Idaho (64)
Illinois (628)
India (31)
Indiana (331)
Iowa (12)
Japan (168)
Kansas (111)
Kentucky (27)
Louisiana (14)
Maine (70)
Maryland (961)
Massachusetts (4925)
Michigan (247)
Minnesota (421)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (70)
New Jersey (1813)
New Mexico (31)
New York (1815)
North Carolina (1127)
North Dakota (9)
Northern California (2736)
Ohio (218)
Oklahoma (15)
Oregon (48)
Pennsylvania (1418)
Puerto Rico (13)
Rhode Island (36)
South America (1652)
South Carolina (23)
South Dakota (1)
Southern California (2370)
Tennessee (104)
Texas (963)
United States (24667)
Utah (191)
Virginia (170)
Washington D.C. (69)
Washington State (604)
West Virginia (3)
Wisconsin (69)
846,148 Results for "'".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prothena to Report First Quarter 2025 Financial Results on May 8
May 1, 2025
·
1 min read
Press Releases
Exact Sciences Announces First-Quarter 2025 Results
May 1, 2025
·
20 min read
Press Releases
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2025
May 1, 2025
·
19 min read
Press Releases
Bio-Rad Reports First-Quarter 2025 Financial Results
May 1, 2025
·
21 min read
Press Releases
Envoy Medical Reports on First Quarter 2025 Results
Company Provides Update on Its Pivotal Clinical Study for Fully Implanted Cochlear Implant
May 1, 2025
·
13 min read
Press Releases
Rosalind Franklin University Incubator Company Announces Positive Anti-Fibrotic Effects in Lung Disease Model
May 1, 2025
·
1 min read
Press Releases
Tharimmune Abstracts Accepted for Presentation at Upcoming DDW and EASL Conferences
May 1, 2025
·
4 min read
Press Releases
Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
May 1, 2025
·
1 min read
Press Releases
Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET
May 1, 2025
·
3 min read
Press Releases
Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
May 1, 2025
·
5 min read
1 of 84,615
Next
